Results 71 to 80 of about 22,097 (178)

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA

Педиатрическая фармакология, 2010
Experts at FSUE R&D Centre Microgen of the RF’s Healthcare Ministry have developed a national drug designed to prevent rubella — Cultural live vaccine against rubella on the basis of vaccinal strain RA 27/3.
A.N. Mironov, A.A. Tsaan, D.S. Bushmenkov, A.A. Romanova, V.A. Merkulov, N.N. Stepanov   +5 more
doaj   +2 more sources

Two-dose measles-rubella vaccine schedule for measles-rubella elimination. [PDF]

Indian J Med Res, 2023
John TJ.
europepmc   +1 more source

A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine. [PDF]

Int Med Case Rep J, 2023
Achdiat PA, Yunitasari, Usman HA, Maharani RH.   +3 more
europepmc   +1 more source

Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand. [PDF]

Clin Exp Vaccine Res, 2023
Sirithammaphan U, Chaisang U, Pongrattanamarn K.   +2 more
europepmc   +1 more source

Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India

Bulletin of the World Health Organization, 2004
OBJECTIVE: To determine the susceptibility of female eye hospital staff to rubella infection and the potential risk for hospital-based rubella outbreaks. METHODS: A prospective cohort study on the seroprevalence of rubella IgG antibodies was conducted at
Vijayalakshmi Perumalsamy, Anuradha Rajamanickam, Prakash Karthik, Narendran Kalpana, Ravindran Meenakshi, Prajna Lalitha, Brown David, Robertson Susan E.   +7 more
doaj  

Microtitration of Rubella Virus in Monovalent Vaccinal Products

Iranian Journal of Public Health, 2011
Background: Potency test for control of rubella vaccine is a significant factor to qualify production line and vaccination pro­gram. For this reason, WHO recommends to use the microtitration method by both vaccine companies and control laborato­ries ...
F Esna-Ashari, A Shafyi, M Taqavian, A Mohammadi, ZA Sadigh, GhH Sabiri, H Mirshahreza, Z Hamzehloo, F Taleblue, N Sheikh-Mohammadi   +9 more
doaj  

Rubella virus vaccine-induced granulomas: a case in children with ataxia-telangiectasia

Dermatology Reports
Ataxia telangiectasia (AT) is a rare autosomal recessive primary immunodeficiency disorder (PID) resulting from a mutation in the ATM gene, which is involved in DNA repair.
Florine Le Lay, Marianna Deparis, Sylvie Fraitag, Anne Dompmartin   +3 more
doaj   +1 more source

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink. [PDF]

Vaccine X, 2023
Hanson KE, Marin M, Daley MF, Groom HC, Jackson LA, Sy LS, Klein NP, DeSilva MB, Panagiotakopoulos L, Weintraub E, Belongia EA, McLean HQ.   +11 more
europepmc   +1 more source

Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation. [PDF]

Rev Inst Med Trop Sao Paulo, 2023
Randi BA, Fernandes EG, Higashino HR, Lopes MH, Rocha VG, Costa SF, Sartori AMC.   +6 more
europepmc   +1 more source

Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts? [PDF]

Oman Med J, 2022
Al-Mendalawi MD.
europepmc   +1 more source